Gerald B. Pier
Fondateur chez Alopexx Enterprises LLC
Postes actifs de Gerald B. Pier
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Harvard Medical School | Corporate Officer/Principal | - | - |
Alopexx Enterprises LLC
 Alopexx Enterprises LLC BiotechnologyHealth Technology Alopexx Enterprises LLC engages in investing and managing health care companies. It develops medical therapies and devices for infectious diseases, oncology, central nervous system, and orphan diseases. The firm commercializes an alternative for the treatment and prevention of staphylococcal and other bacterial infections and animal vaccines. The company was founded by Daniel R. Vlock, Deborah Ramsdell and Christine de los Reyes in 2011 and is headquartered in Concord, MA. | Directeur Technique/Scientifique/R&D | - | - |
| Fondateur | - | - |
Historique de carrière de Gerald B. Pier
Anciens postes connus de Gerald B. Pier
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ALOPEXX, INC. | Fondateur | 23/03/2019 | - |
| Corporate Officer/Principal | 23/03/2019 | - |
Formation de Gerald B. Pier
| University of the Pacific | Undergraduate Degree |
| University of California, Berkeley | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
Opérationnelle
| Founder | 2 |
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
Sectorielle
| Consumer Services | 4 |
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Alopexx, Inc.
 Alopexx, Inc. BiotechnologyHealth Technology Alopexx, Inc. develops novel, broad-spectrum immune medicated therapeutics for the prevention and treatment of bacterial, fungal and parasitic microbial infections. The company was founded by Daniel R. Vlock and Gerald B. Pier and is headquartered in Cambridge, MA. | Health Technology |
Alopexx Enterprises LLC
Alopexx Enterprises LLC BiotechnologyHealth Technology Alopexx Enterprises LLC engages in investing and managing health care companies. It develops medical therapies and devices for infectious diseases, oncology, central nervous system, and orphan diseases. The firm commercializes an alternative for the treatment and prevention of staphylococcal and other bacterial infections and animal vaccines. The company was founded by Daniel R. Vlock, Deborah Ramsdell and Christine de los Reyes in 2011 and is headquartered in Concord, MA. | Health Technology |
- Bourse
- Insiders
- Gerald B. Pier
- Expérience
